Publications of R. Hohlfeld

Haghikia, A.; Fischer, M.; Hellwig, K.; Linker, R.; Chan, A.; Hohlfeld, R.; Gold, R.: Open use of natalizumab. Neutralising antibodies and clinical data. Nervenarzt 79 (6), pp. 716 - 719 (2008)

Hoffmann, L. A.; Lohse, P.; König, F. B.; Feneberg, W.; Hohlfeld, R.; Kümpfel, T.: TNFRSF1A R92Q mutation in association with a multiple sclerosis-like demyelinating syndrome. Neurology 70 (13 Pt 2), pp. 1155 - 1156 (2008)

Jarius, S.; Paul, F.; Franciotta, D.; Waters, P.; Zipp, F.; Hohlfeld, R.; Vincent, A.; Wildemann, B.: Mechanisms of disease: Aquaporin-4 antibodies in neuromyelitis optica. Nature Clinical Practice Neurology 4 (4), pp. 202 - 214 (2008)

Kümpfel, T.; Hoffmann, L. A.; Pellkofer, H.; Pöllmann, W.; Feneberg, W.; Hohlfeld, R.; Lohse, P.: Multiple sclerosis and the TNFRSF1A R92Q mutation: Clinical characteristics of 21 cases. Neurology 71, pp. 1812 - 1820 (2008)

Sommer, N.; Tackenberg, B.; Hohlfeld, R.: The immunopathogenesis of myasthenia gravis. Handb Clin Neurol 91 (Chapter 5), pp. 169 - 212 (2008)

Wiendl, H.; Toyka, K. V.; Rieckmann, P.; Gold, R.; Hartung, H. P.; Hohlfeld, R.: Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations. Journal of Neurology 255 (10), pp. 1449 - 1463 (2008)

Hohlfeld, R.; Dornmair, K.: Revisiting the immunopathogenesis of the inflammatory myopathies. Neurology 69 (21), pp. 1966 - 1967 (2007)

Junker, A.; Ivanidze, J.; Malotka, J.; Eiglmeier, I.; Lassmann, H.; Wekerle, H.; Meinl, E.; Hohlfeld, R.; Dornmair, K.: Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain 130, pp. 2789 - 2799 (2007)

Krumbholz, M.; Theil, D.; Steinmeyer, F.; Cepok, S.; Hemmer, B.; Hofbauer, M.; Farina, C.; Derfuss, T.; Junker, A.; Arzberger, T. et al.; Sinicina, I.; Hartle, C.; Newcombe, J.; Hohlfeld, R.; Meinl, E.: CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions. Journal of Neuroimmunology 190 (1-2), pp. 72 - 79 (2007)

Mathey, E. K.; Derfuss, T.; Storch, M. K.; Williams, K. R.; Hales, K.; Woolley, D. R.; Al-Hayani, A.; Davies, S. N.; Rasband, M. N.; Olsson, T. et al.; Moldenhauer, A.; Velhin, S.; Hohlfeld, R.; Meinl, E.; Linington, C.: Neurofascin as a novel target for autoantibody-mediated axonal injury. Journal of Experimental Medicine 204 (10), pp. 2363 - 2372 (2007)

Weber, M. S.; Hohlfeld, R.; Zamvil, S. S.: Mechanism of action of glatiramer acetate in treatment of multiple sclerosis. Neurotherapeutics 4 (4), pp. 647 - 653 (2007)

Klatt, J.; Hartung, H.-P.; Hohlfeld, R.: FTY720 (Fingolimod) als neue Therapiemöglichkeit der Multiplen Sklerose. Der Nervenarzt 78, pp. 1200 - 1208 (2007)

Hohlfeld, R.; Kerschensteiner, M.; Meinl, E.: Dual role of inflammation in CNS disease. Neurology 68 (3), pp. 58 - 63 (2007)

Jarius, S.; Eichhorn, P.; Albert, M. H.; Wagenpfeil, S.; Wick, M.; Belohradsky, B. H.; Hohlfeld, R.; Jenne, D. E.; Voltz, R.: Intravenous immunoglobulins contain naturally occurring antibodies that mimic antineutrophil cytoplasmic antibodies and activate neutrophils in a TNFα-dependent and Fc-receptor-independent way. Blood 109 (10), pp. 4376 - 4382 (2007)

Jarius, S.; Friedemann, P.; Franciotta, D.; Aktas, O.; Hohlfeld, R.; Zipp, F.; Vincent, A.: Revised diagnostic criteria for neuromyelitis optica-incorporation of NMO-IgG status. Nature Clinical Practise Neurology 5, pp. 2774 - 2783 (2007)

Lisak, R. P.; Hohlfeld, R.: Neurodegeneration, neuroprotection, glial cells, and myelin in multiple sclerosis. Neurology 68 (Suppl. 3), p. S1 - S1 (2007)

Paul, F.; Jarius, S.; Aktas, O.; Bluthner, M.; Bauer, O.; Appelhans, H.; Franciotta, D.; Bergamaschi, R.; Littleton, E.; Palace, J. et al.; Seelig, H.-P.; Hohlfeld, R.; Vincent, A.; Zipp, F.: Antibody to aquaporin 4 in the diagnosis of neuomyelitis optica. PLoS Medicine 4 (4), e133, pp. 0669 - 0674 (2007)

Jarius, S.; Franciotta, D.; Bergamaschi, R.; Wright, H.; Littleton, E.; Palace, J.; Hohlfeld, R.; Vincent, A.: NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 68 (13), pp. 1076 - 1077 (2007)

Hoffmann, L. A.; Krumbholz, M.; Faber, H.; Kuempfel, T.; Starck, M.; Pöllmann, W.; Meinl, E.; Hohlfeld, R.: Multiple sclerosis: Relating MxA transcription to anti-interferon-β-neutralizing antibodies. Neurology 68 (12), pp. 958 - 959 (2007)

Krumbholz, M.; Pellkofer, H.; Gold, R.; Hoffmann, L.; Hohlfeld, R.; Kümpfel, T.: Delayed allergic reaction to natalizumab associated with early formation of neutralizing antibodies. Archives of Neurology 64, pp. 1331 - 1333 (2007)